Tumour-shrinking decoction for symptomatic uterine fibroids: a double-blind, randomised, two-dose trial (abridged secondary publication)

被引：0
|
作者：
Meng, W. [1 ]
Lao, L. [1 ]
Zhang, Z. J. [1 ]
Lin, W. L. [2 ]
Zhang, Y. B. [1 ]
Yeung, W. F. [3 ]
Yu, Y. M. B. [3 ]
Ng, H. Y. E. [1 ]
Chen, J. P. [1 ]
Su, J. [1 ]
Rong, J. H. [1 ]
Lam, P. Y. F. [1 ]
Lee, E. [1 ]
机构：
[1] Univ Hong Kong, LKS Fac Med, Hong Kong, Peoples R China
[2] Chinese Univ Hong Kong, Fac Med, Hong Kong Inst Integrat Med, Hong Kong, Peoples R China
[3] Hong Kong Polytech Univ, Sch Nursing, Hong Kong, Peoples R China
来源：
HONG KONG MEDICAL JOURNAL | 2021年 / 27卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：8 / 10
页数：3
相关论文
共 31 条
  • [21] Safety and efficacy of factorXIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP) : a phase 2, international, randomised, double-blind, placebo-controlled, dose-finding trial
    Sharma, Mukul
    Molina, Carlos A.
    Toyoda, Kazunori
    Bereczki, Daniel
    Bangdiwala, Shrikant, I
    Kasner, Scott E.
    Lutsep, Helmi L.
    Tsivgoulis, Georgios
    Ntaios, George
    Czlonkowska, Anna
    Shuaib, Ashfaq
    Amarenco, Pierre
    Endres, Matthias
    Yoon, Byung-Woo
    Tanne, David
    Toni, Danilo
    Yperzeele, Laetitia
    von Weitzel-Mudersbach, Paul
    Silva, Gisele Sampaio
    Avezum, Alvaro
    Dawson, Jesse
    Strbian, Daniel
    Tatlisumak, Turgut
    Eckstein, Jens
    Ameriso, Sebastian F.
    Weber, Joerg R.
    Sandset, Else Charlotte
    Pogosova, Nana Goar
    Lavados, Pablo M.
    Arauz, Antonio
    Gailani, David
    Diener, Hans-Christoph
    Bernstein, Richard A.
    Cordonnier, Charlotte
    Kahl, Anja
    Abelian, Grigor
    Donovan, Mark
    Pachai, Chahin
    Li, Danshi
    Hankey, Graeme J.
    LANCET NEUROLOGY, 2024, 23 (01): : 46 - 59
  • [22] Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial
    Ishola, David
    Manno, Daniela
    Afolabi, Muhammed O.
    Keshinro, Babajide
    Bockstal, Viki
    Rogers, Baimba
    Owusu-Kyei, Kwabena
    Serry-Bangura, Alimamy
    Swaray, Ibrahim
    Lowe, Brett
    Kowuor, Dickens
    Baiden, Frank
    Mooney, Thomas
    Smout, Elizabeth
    Kohn, Brian
    Otieno, Godfrey T.
    Jusu, Morrison
    Foster, Julie
    Samai, Mohamed
    Deen, Gibrilla Fadlu
    Larson, Heidi
    Lees, Shelley
    Goldstein, Neil
    Gallagher, Katherine E.
    Gaddah, Auguste
    Heerwegh, Dirk
    Callendret, Benoit
    Luhn, Kerstin
    Robinson, Cynthia
    Leyssen, Maarten
    Greenwood, Brian
    Douoguih, Macaya
    Leigh, Bailah
    Watson-Jones, Deborah
    LANCET INFECTIOUS DISEASES, 2022, 22 (01): : 97 - 109
  • [23] Two dose levels of once-weekly fosravuconazole versus daily itraconazole in combination with surgery in patients with eumycetoma in Sudan: a randomised, double-blind, phase 2, proof-of-concept superiority trial
    Fahal, Ahmed H.
    Ahmed, Eiman Siddig
    Bakhiet, Sahar Mubarak
    Bakhiet, Osama Elhadi
    Fahal, Lamis Ahmed
    Mohamed, Abubakar Ahmed
    Mohamedelamin, El Semani Widaa
    Bahar, Mustafa El Nour
    Attalla, Hadil Yassir
    Siddig, Emmanuel Edwar
    Mhmoud, Najwa A.
    Musa, Ahmed Mudawi
    van de Sande, Wendy W. J.
    Scherrer, Bruno
    Oyieko, Peelen
    Egondi, Thaddaeus W.
    Onyango, Kevin
    Hata, Katsura
    Chu, Wan-Yu
    Dorlo, Thomas P. C.
    Brueggemann, Roger J.
    Nyaoke, Borna A.
    Strub-Wourgaft, Nathalie
    Zijlstra, Eduard
    LANCET INFECTIOUS DISEASES, 2024, 24 (11): : 1254 - 1265
  • [24] Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone (vol 11, pg E1743, 2023)
    不详
    LANCET GLOBAL HEALTH, 2024, 12 (01): : E32 - E32
  • [25] Effect of monthly high-dose vitamin D supplementation on falls and non-vertebral fractures: secondary and post-hoc outcomes from the randomised, double-blind, placebo-controlled ViDA trial
    Khaw, Kay-Tee
    Stewart, Alistair W.
    Waayer, Debbie
    Lawes, Carlene M. M.
    Toop, Les
    Camargo, Carlos A., Jr.
    Scragg, Robert
    LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (06): : 438 - 447
  • [26] Negative Clinical Results from a Randomised, Double-Blind, Placebo-Controlled Trial Evaluating the Efficacy of Two Doses of Immunologically Enhanced, Grass Subcutaneous Immunotherapy Despite Dose-Dependent Immunological Response
    Kleine-Tebbe, Joerg
    Walmar, Mikkel
    Bitsch-Jensen, Klaus
    Decot, Elke
    Pfaar, Oliver
    Fernandez de Rojas, Dolores Hernandez
    Rodriguez, Fernando
    CLINICAL DRUG INVESTIGATION, 2014, 34 (08) : 577 - 586
  • [27] Negative Clinical Results from a Randomised, Double-Blind, Placebo-Controlled Trial Evaluating the Efficacy of Two Doses of Immunologically Enhanced, Grass Subcutaneous Immunotherapy Despite Dose-Dependent Immunological Response
    Jörg Kleine-Tebbe
    Mikkel Walmar
    Klaus Bitsch-Jensen
    Elke Decot
    Oliver Pfaar
    Dolores Hernández Fernández de Rojas
    Fernando Rodriguez
    Clinical Drug Investigation, 2014, 34 : 577 - 586
  • [28] Chemoprevention with low-dose aspirin, mesalazine, or both in patients with familial adenomatous polyposis without previous colectomy (J-FAPP Study IV) : a multicentre, double-blind, randomised, two-by-two factorial design trial
    LaCourse, Kaitlyn D.
    Johnston, Christopher D.
    Bullman, Susan
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (06): : 498 - 509
  • [29] Safety and long-term immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in adults in Sierra Leone: a combined open-label, non-randomised stage 1, and a randomised, double-blind, controlled stage 2 trial (vol 22, pg 97, 2022)
    Ishola, D.
    Manno, D.
    Afolabi, M. O.
    LANCET INFECTIOUS DISEASES, 2023, 23 (09): : E337 - E337
  • [30] Effect of Intravenous Zoledronic Acid on Total Knee Replacement in Patients With Symptomatic Knee Osteoarthritis and Without Severe Joint Space Narrowing: A Prespecified Secondary Analysis of a Two-Year, Multicenter, Double-Blind, Placebo-Controlled Clinical Trial
    Cai, Guoqi
    Laslett, Laura L.
    Thompson, Michael
    Cicuttini, Flavia
    Hill, Catherine
    Wluka, Anita E.
    March, Lyn
    Wang, Yuanyuan
    Otahal, Petr
    Stoney, James D.
    Antony, Benny
    Buttigieg, Kathy
    Winzenberg, Tania
    Jones, Graeme
    Aitken, Dawn
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 (07) : 1047 - 1053
1234